Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies D Li, CS McIntosh, FL Mastaglia, SD Wilton, MT Aung-Htut Translational neurodegeneration 10 (1), 16, 2021 | 55 | 2021 |
A comparison of carcass decomposition and associated insect succession onto burnt and unburnt pig carcasses CS McIntosh, IR Dadour, SC Voss International Journal of Legal Medicine 131, 835-845, 2017 | 39 | 2017 |
Systematic approach to developing splice modulating antisense oligonucleotides MT Aung-Htut, CS McIntosh, KA Ham, IL Pitout, LL Flynn, K Greer, ... International journal of molecular sciences 20 (20), 5030, 2019 | 21 | 2019 |
In vitro validation of phosphorodiamidate morpholino oligomers MT Aung-Htut, CS McIntosh, KA West, S Fletcher, SD Wilton Molecules 24 (16), 2922, 2019 | 20 | 2019 |
Removal of the polyglutamine repeat of ataxin-3 by redirecting pre-mRNA processing CS McIntosh, MT Aung-Htut, S Fletcher, SD Wilton International Journal of Molecular Sciences 20 (21), 5434, 2019 | 12 | 2019 |
Polyglutamine ataxias: from clinical and molecular features to current therapeutic strategies CS McIntosh, MT Aung-Htut, S Fletcher, SD Wilton J. Genet. Syndr. Gene Ther 8 (2), 2017 | 11 | 2017 |
Polyglutamine ataxias: our current molecular understanding and what the future holds for antisense therapies CS McIntosh, D Li, SD Wilton, MT Aung-Htut Biomedicines 9 (11), 1499, 2021 | 10 | 2021 |
Induction of cryptic pre-mRNA splice-switching by antisense oligonucleotides KA Ham, NP Keegan, CS McIntosh, MT Aung-Htut, K Zaw, K Greer, ... Scientific Reports 11 (1), 15137, 2021 | 8 | 2021 |
Splice correction therapies for familial hypercholesterolemic patients with low-density lipoprotein receptor mutations CS McIntosh, GF Watts, SD Wilton, MT Aung-Htut Current Opinion in Lipidology 32 (6), 355-362, 2021 | 2 | 2021 |
Cryptic U2-dependent pre-mRNASplice site usage induced by splice switching antisense oligonucleotides K Ham, N Keegan, C McIntosh, M Aung-Htut, K Zaw, K Greer, S Fletcher, ... | 1 | 2021 |
Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies. Biomedicines 2021, 9, 1499 CS McIntosh, D Li, SD Wilton, MT Aung-Htut s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
The use of antisense oligonucleotide-mediated exon skipping to treat spinocerebellar ataxia type 3 CS McIntosh, MT Aung-Htut, S Fletcher, SD Wilton Journal of Gene Medicine 20 (1), 2018 | 1 | 2018 |
Induced alternative splicing an opportunity to study PCSK9 protein isoforms at physiologically relevant concentrations JM Cale, KA Ham, D Li, CS McIntosh, GF Watts, SD Wilton, MT Aung-Htut Scientific reports 13 (1), 19725, 2023 | | 2023 |
Novel susceptibility genes and molecular mechanisms identified in relation to mitochondrial dysfunctions in Parkinson’s disease D Li, S McDowall, C McIntosh, D Eddy, F Zhang, T Wang | | 2023 |
Antisense oligonucleotide-mediated therapeutic strategies for neurodegenerative repeat expansion diseases CS McIntosh Murdoch University, 2020 | | 2020 |
The effects of burning on carcass decomposition and associated insect succession in Western Australia CS McIntosh | | 2015 |
Does burning effect decomposition and insect succession on pig carcasses? PA Magni, CS McIntosh, SC Voss, I Dadour 22nd International Symposium of the Australian and New Zealand Forensic …, 2014 | | 2014 |